Your browser doesn't support javascript.
loading
Do Patients Discontinue Overactive Bladder Medications after Sacral Neuromodulation?
Amin, Katherine; Moskowitz, Dena; Kobashi, Kathleen C; Lee, Una J; Lucioni, Alvaro.
Affiliation
  • Amin K; Female Pelvic Medicine and Reconstructive Surgery, Section of Urology, Virginia Mason Medical Center , Seattle , Washington.
  • Moskowitz D; Female Pelvic Medicine and Reconstructive Surgery, Section of Urology, Virginia Mason Medical Center , Seattle , Washington.
  • Kobashi KC; Female Pelvic Medicine and Reconstructive Surgery, Section of Urology, Virginia Mason Medical Center , Seattle , Washington.
  • Lee UJ; Female Pelvic Medicine and Reconstructive Surgery, Section of Urology, Virginia Mason Medical Center , Seattle , Washington.
  • Lucioni A; Female Pelvic Medicine and Reconstructive Surgery, Section of Urology, Virginia Mason Medical Center , Seattle , Washington.
J Urol ; 201(5): 973-978, 2019 05.
Article in En | MEDLINE | ID: mdl-30694936

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Electric Stimulation Therapy / Botulinum Toxins, Type A / Urinary Bladder, Overactive / Urological Agents Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Urol Year: 2019 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Electric Stimulation Therapy / Botulinum Toxins, Type A / Urinary Bladder, Overactive / Urological Agents Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Urol Year: 2019 Type: Article